EGFR and neoplasm: Importantly, silencing TNS4 mitigated the effects of miR-1224-5p loss on EGFR upregulation and signaling activation, as well as inhibiting in vitro proliferation, colony formation, migration, invasion, and in vivo tumor growth [89].